Condition: Mild Cognitive Impairment (MCI) Amnestic · Parkinson Disease (PD) · Healthy Participants · Sponsor: Cilcare SAS
The study aims to phenotype hearing in patients with early stage of neurodegenerative disorders to explore the prevalence of various hearing disorders in comparison to a control population. Specific focus is made on patients with speech-in-noise intelligibiltiy deficit despite normal tonal audiograms referred to as hidden hearing loss, with potential identification of associated biomarkers.
This description comes directly from the study's public registry record.
Laura BREDA, Master's degree · +33769042226 · laura.breda@cilcare.com
Always discuss trial participation with your own doctor first.
| CHU Gui de Chauliac | Montpellier, France | Recruiting |
| CHU Nice | Nice, France | Recruiting |
| CHU Carémeau | Nîmes, France | Recruiting |
| Hospices Civils de Lyon, Hôpital des Charpennes | Villeurbanne, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07083089